S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MallinckrodtAgile TherapeuticsSpero TherapeuticsREDHILL BIOPHAR/SFortress Biotech
SymbolNYSE:MNKNASDAQ:AGRXNASDAQ:SPRONASDAQ:RDHLNASDAQ:FBIO
Price Information
Current Price$3.10$2.54$13.46$6.38$2.70
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.81.61.51.41.3
Analysis Score2.93.43.53.53.5
Community Score3.13.12.62.92.6
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.00.00.0
Earnings & Valuation Score1.90.60.60.60.6
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$4.22$6.50$23.00$14.50$10.50
% Upside from Price Target36.20% upside155.91% upside70.88% upside127.27% upside288.89% upside
Trade Information
Market Cap$261.81 million$221.52 million$277.21 million$229.61 million$221.84 million
Beta3.421.461.971.722.19
Average Volume6,780,7372,977,435143,316353,812632,444
Sales & Book Value
Annual Revenue$3.16 billionN/A$18.15 million$6.29 million$36.63 million
Price / Sales0.08N/A15.2735.776.08
Cashflow$22.14 per shareN/AN/AN/AN/A
Price / Cash0.14N/AN/AN/AN/A
Book Value$23.08 per share$0.77 per share$3.90 per share$2.74 per share$1.02 per share
Price / Book0.13N/A3.452.332.65
Profitability
Net Income$-996,500,000.00$-18,610,000.00$-60,920,000.00$-42,300,000.00$-39,960,000.00
EPS$8.88($0.38)($3.35)($1.40)($0.73)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio0.76N/AN/AN/AN/A
P/E Growth$0.03N/AN/AN/AN/A
Net Margins-39.56%N/A-654.03%-883.97%-124.73%
Return on Equity (ROE)29.14%-45.62%-88.22%-125.23%-58.31%
Return on Assets (ROA)7.09%-40.19%-70.36%-64.50%-20.17%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.50%0.17%0.05%1.88%1.26%
Current Ratio1.46%33.69%4.31%5.83%3.07%
Quick Ratio1.20%33.69%4.31%5.67%3.05%
Ownership Information
Institutional Ownership Percentage78.19%37.87%50.58%17.55%15.78%
Insider Ownership Percentage3.14%8.50%18.34%N/A33.10%
Miscellaneous
Employees3,40013577593
Shares Outstanding84.46 million87.21 million20.60 million35.27 million82.47 million
Next Earnings Date8/4/2020 (Confirmed)8/6/2020 (Estimated)8/13/2020 (Estimated)7/28/2020 (Estimated)8/14/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.